← ANALYST RATINGS · TIPRANKS
Integra Lifesciences (IART): analyst forecast and price target
Analyst consensus
Hold0 Buy6 Hold1 Sell
Ratings of 7 analysts in the last 3 months12-month forecast
Based on 7 price targets given in the last 3 months, the average target is $16.00, the highest $19.00, the lowest $15.00. The average is +21.1% from the last price of $13.21.
Analyst ratings 11
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Richard Newitter★★★★★★★★★★#1772 · hits 48% · avg +6.6% | Truist Financial | $19.00 → $15.00−21.1% | Hold | +13.6% | Reiterated | 14.10.26on TipRanks 08:35 | −3.8%next day +2.4% | ↗ |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $12.00 → $13.00+8.3% | Hold | −1.6% | Reiterated | 10.10.26on TipRanks 01:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $12.00 → $13.00+8.3% | Hold | −1.6% | Upgrade | 10.10.26on TipRanks 01:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $12.50 → $13.00+4.0% | Hold | −1.6% | Reiterated | 10.10.26on TipRanks 01:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $12.00 → $12.50+4.2% | Sell | −5.4% | Reiterated | 10.10.26on TipRanks 01:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $12.50 → $13.00+4.0% | Hold | −1.6% | Reiterated | 10.10.26on TipRanks 01:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $12.50 → $13.00+4.0% | Hold | −1.6% | Reiterated | 10.10.26on TipRanks 01:05 | — | |
| Ravi Misra★★★★★★★★★★#11202 · hits 35% · avg −10.7% | Truist Financial | — | Hold | — | Reiterated | 05.10.26on TipRanks 08:45 | +4.1%next day −0.3% · 5 days +4.8% | ↗ |
| Joanne Wuensch★★★★★★★★★★#3684 · hits 55% · avg +2.3% | Citi | $19.00 → $15.00−21.1% | Hold | +13.6% | Reiterated | 05.10.26on TipRanks 07:07 | +4.1%next day −0.3% · 5 days +4.8% | ↗ |
| Vik Chopra★★★★★★★★★★#6076 · hits 45% · avg +1.9% | BMO Capital | $18.00 → $15.00−16.7% | Hold | +13.6% | Reiterated | 02.10.26on TipRanks Oct 5 08:05 | −21.9%next day +4.1% · 5 days +4.8% | ↗ |
| Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% | Wells Fargo | $18.00 → $15.00−16.7% | Hold | +13.6% | Reiterated | 02.10.26on TipRanks Oct 3 09:45 | −21.9%next day +4.1% · 5 days +4.8% | ↗ |
| Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% | BTIG | — | Hold | — | Reiterated | 02.10.26on TipRanks Oct 3 09:35 | −21.9%next day +4.1% · 5 days +4.8% | ↗ |
| Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% | J.P. Morgan | $17.00 | Sell | +28.7% | Reiterated | 04.08.26on TipRanks Aug 5 08:08 | −1.7%next day −1.0% · 5 days −2.9% | ↗ |
| Patrick Wood★★★★★★★★★★#10768 · hits 50% · avg −2.1% | UBS | $19.00 | Hold | +43.8% | Initiated | 28.07.26on TipRanks 06:50 | +0.9%next day −15.0% · 5 days −13.5% | ↗ |
| David Toung★★★★★★★★★★#1098 · hits 63% · avg +9.1% | Argus Research | $25.00 | Buy | +89.3% | Upgrade | 17.06.26on TipRanks Jun 18 08:00 | −1.6%next day +1.2% · 5 days +5.9% | ↗ |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | — | Sell | — | Reiterated | 14.05.26on TipRanks 11:25 | −3.5%next day −1.6% · 5 days +5.0% | ↗ |
| Unknown Analyst | Jefferies | $27.00 | Buy | +104.4% | Reiterated | 06.05.26on TipRanks May 7 05:33 | +4.5%next day −2.8% · 5 days +5.3% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Integra Lifesciences
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $18.33 at a price of $16.28 (+12.6%); now: $16.00 at $13.21 (+21.1%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Buy | 0 | 1 | 1 | 1 | 0 | 0 |
| Hold | 7 | 6 | 10 | 8 | 7 | 7 |
| Sell | 4 | 3 | 2 | 1 | 1 | 1 |
Earnings and sales forecast
Next report: 21.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.56 (from $0.54 to $0.57). Last quarter: $0.56.
Sales
Next quarter’s sales estimate — $413M (from $410M to $419M). Last quarter: $419M.
Best top-analyst consensus in the sector · Healthcare
About Integra Lifesciences
- CEO: Stuart Essig
- Employees: 4,427
- 1100 Campus Road, Princeton, NJ, 08540, US
- www.integralife.com
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide ar
Data from the stock’s TipRanks forecast page, read 74 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗